The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
Blood Cancer J
.
2019 Jan 15;9(2):5.
doi: 10.1038/s41408-018-0169-1.
Authors
Sausan A Moharram
1
2
,
Kinjal Shah
1
2
,
Fatima Khanum
1
2
,
Lars Rönnstrand
1
2
3
,
Julhash U Kazi
4
5
Affiliations
1
Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden.
2
Lund Stem Cell Center, Department of Laboratory Medicine, Lund University, Lund, Sweden.
3
Division of Oncology, Skåne University Hospital, Lund, Sweden.
4
Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden. kazi.uddin@med.lu.se.
5
Lund Stem Cell Center, Department of Laboratory Medicine, Lund University, Lund, Sweden. kazi.uddin@med.lu.se.
PMID:
30647405
PMCID:
PMC6333797
DOI:
10.1038/s41408-018-0169-1
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't